<DOC>
	<DOCNO>NCT02030821</DOCNO>
	<brief_summary>The purpose study determine relative effectiveness two drug agent , Tranexamic acid ( TXA ) aminocaproic acid ( Amicar ) , act similar mechanism action . These agent use decrease blood loss result major surgery , like total joint arthroplasty . A secondary goal investigate cost-analysis total hospitalization . Both TXA Amicar currently use care patient undergoing total joint arthroplasty . Subjects randomly assign TXA Amicar arm . All data need study include blood loss , need transfusion , preoperative low postoperative hematocrit hemoglobin , complication collect hospitalization stay . Our Hypothesis TXA Amicar similar effectiveness prevent intraoperative blood loss need transfusion post-op Amicar . A detailed cost analysis show overall cost perform operative procedure , include transfusion , OR time , total cost associate admission cost decrease Amicar compare TXA .</brief_summary>
	<brief_title>TXA vs. Amicar Total Knee Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Aminocaproic Acid</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients elect undergo primary total hip knee arthroplasty History stent Myocardial infarction , Cerebrovascular accident stroke Deep venous thrombus Pulmonary embolus Late onset color blindness Hypercoagulable state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>